scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Stefan Pöhlmann | Q37063445 |
P2093 | author name string | Doms RW | |
Baribaud F | |||
P2860 | cites work | Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 |
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV transmission | Q49029021 |
P1104 | number of pages | 6 | |
P304 | page(s) | 1-6 | |
P577 | publication date | 2001-07-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission | |
P478 | volume | 286 |
Q78029025 | AIDS models: microbicides could learn from vaccines |
Q37059589 | Binding of Human Immunodeficiency Virus Type 1 to Immature Dendritic Cells Can Occur Independently of DC-SIGN and Mannose Binding C-Type Lectin Receptors via a Cholesterol-Dependent Pathway |
Q38159719 | Bitter-sweet symphony: glycan-lectin interactions in virus biology |
Q35903597 | Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4+ Th-Cells |
Q42802871 | C-type lectin LSECtin interacts with DC-SIGNR and is involved in hepatitis C virus binding. |
Q37602527 | Controversies in the pathogenesis of HIV-associated renal diseases |
Q33755099 | Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes |
Q38344672 | DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. |
Q42212630 | DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer |
Q28204447 | DC-SIGN: escape mechanism for pathogens |
Q34349275 | Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover |
Q33922449 | Dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin mediates HIV-1 infection of and transmission by M2a-polarized macrophages in vitro |
Q38295059 | Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering |
Q36237524 | Emerging drug targets for antiretroviral therapy |
Q36580487 | Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression |
Q34331629 | Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques |
Q24537674 | Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission |
Q36949588 | Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. |
Q37145333 | Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection |
Q36923795 | HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. |
Q34222643 | HIV-1 Nef enhances dendritic cell-mediated viral transmission to CD4+ T cells and promotes T-cell activation |
Q34328935 | HIV-1 gp120 binding to dendritic cell receptors mobilize the virus to the lymph nodes, but the induced IL-4 synthesis by FcepsilonRI+ hematopoietic cells damages the adaptive immunity--a review, hypothesis, and implications |
Q36509382 | Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry |
Q30448571 | Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection |
Q52593223 | Inefficient HIV-1 trans infection of CD4+ T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN. |
Q35709090 | Inhibiting sexual transmission of HIV-1 infection |
Q34976132 | Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. |
Q39521282 | Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. |
Q44640239 | Methamphetamine modulates DC-SIGN expression by mature dendritic cells |
Q42681116 | Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR. |
Q36957775 | Mucosal immunology of HIV infection |
Q36099045 | N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization |
Q38306096 | NMR evidence for oligosaccharide release from the dendritic-cell specific intercellular adhesion molecule 3-grabbing non-integrin-related (CLEC4M) carbohydrate recognition domain at low pH. |
Q37767654 | Potential of carbohydrate-binding agents as therapeutics against enveloped viruses |
Q39684486 | Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells |
Q37833361 | Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission |
Q93122641 | Schistosoma mansoni soluble egg antigen (SEA) and recombinant Omega-1 modulate induced CD4+ T-lymphocyte responses and HIV-1 infection in vitro |
Q34341843 | The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. |
Q73371544 | The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS |
Q42997232 | The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. |
Q34332519 | Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein |
Q24656887 | Utilization of DC-SIGN for entry of feline coronaviruses into host cells |
Q38112012 | Virus-receptor interactions and receptor-mediated virus entry into host cells |
Search more.